Copyright Reports & Markets. All rights reserved.

Europe Digital Biomarkers Market Report 2019

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Definition and Specification
    • 1.2 Report Overview
      • 1.2.1 Manufacturers Overview
      • 1.2.2 Regions Overview
      • 1.2.3 Type Overview
      • 1.2.4 Application Overview
    • 1.3 Industrial Chain
      • 1.3.1 Digital Biomarkers Overall Industrial Chain
      • 1.3.2 Upstream
      • 1.3.3 Downstream
    • 1.4 Industry Situation
      • 1.4.1 Industrial Policy
      • 1.4.2 Product Preference
      • 1.4.3 Economic/Political Environment
    • 1.5 SWOT Analysis

    2 Market Analysis by Types

    • 2.1 Overall Market Performance(Volume)
      • 2.1.1 Wellness Market Performance (Volume)
      • 2.1.2 Disease Market Performance (Volume)
      • 2.1.3 Drugs Market Performance (Volume)
    • 2.2 Overall Market Performance(Value)
      • 2.2.1 Wellness Market Performance (Value)
      • 2.2.2 Disease Market Performance (Value)
      • 2.2.3 Drugs Market Performance (Value)

    3 Product Application Market

    • 3.1 Overall Market Performance (Volume)
      • 3.1.1 Sleep and Movement Market Performance (Volume)
      • 3.1.2 Cardiovascular Market Performance (Volume)
      • 3.1.3 Mood and Behavior Market Performance (Volume)
      • 3.1.4 Pain Management Market Performance (Volume)
      • 3.1.5 Neurodegenerative Disorders Market Performance (Volume)
      • 3.1.6 Respiratory Conditions Market Performance (Volume)

    4 Manufacturers Profiles/Analysis

    • 4.1 ActiGraph
      • 4.1.1 ActiGraph Profiles
      • 4.1.2 ActiGraph Product Information
      • 4.1.3 ActiGraph Digital Biomarkers Business Performance
      • 4.1.4 ActiGraph Digital Biomarkers Business Development and Market Status
    • 4.2 Akili Interactive Labs
      • 4.2.1 Akili Interactive Labs Profiles
      • 4.2.2 Akili Interactive Labs Product Information
      • 4.2.3 Akili Interactive Labs Digital Biomarkers Business Performance
      • 4.2.4 Akili Interactive Labs Digital Biomarkers Business Development and Market Status
    • 4.3 AliveCor
      • 4.3.1 AliveCor Profiles
      • 4.3.2 AliveCor Product Information
      • 4.3.3 AliveCor Digital Biomarkers Business Performance
      • 4.3.4 AliveCor Digital Biomarkers Business Development and Market Status
    • 4.4 Fitbit
      • 4.4.1 Fitbit Profiles
      • 4.4.2 Fitbit Product Information
      • 4.4.3 Fitbit Digital Biomarkers Business Performance
      • 4.4.4 Fitbit Digital Biomarkers Business Development and Market Status
    • 4.5 HumanAPI
      • 4.5.1 HumanAPI Profiles
      • 4.5.2 HumanAPI Product Information
      • 4.5.3 HumanAPI Digital Biomarkers Business Performance
      • 4.5.4 HumanAPI Digital Biomarkers Business Development and Market Status
    • 4.6 Novartis
      • 4.6.1 Novartis Profiles
      • 4.6.2 Novartis Product Information
      • 4.6.3 Novartis Digital Biomarkers Business Performance
      • 4.6.4 Novartis Digital Biomarkers Business Development and Market Status
    • 4.7 Pfizer
      • 4.7.1 Pfizer Profiles
      • 4.7.2 Pfizer Product Information
      • 4.7.3 Pfizer Digital Biomarkers Business Performance
      • 4.7.4 Pfizer Digital Biomarkers Business Development and Market Status
    • 4.8 F. Hoffmann-La Roche
      • 4.8.1 F. Hoffmann-La Roche Profiles
      • 4.8.2 F. Hoffmann-La Roche Product Information
      • 4.8.3 F. Hoffmann-La Roche Digital Biomarkers Business Performance
      • 4.8.4 F. Hoffmann-La Roche Digital Biomarkers Business Development and Market Status
    • 4.9 Sanofi
      • 4.9.1 Sanofi Profiles
      • 4.9.2 Sanofi Product Information
      • 4.9.3 Sanofi Digital Biomarkers Business Performance
      • 4.9.4 Sanofi Digital Biomarkers Business Development and Market Status
    • 4.10 Takeda Pharmaceuticals
      • 4.10.1 Takeda Pharmaceuticals Profiles
      • 4.10.2 Takeda Pharmaceuticals Product Information
      • 4.10.3 Takeda Pharmaceuticals Digital Biomarkers Business Performance
      • 4.10.4 Takeda Pharmaceuticals Digital Biomarkers Business Development and Market Status
    • 4.11 Verily Life Science

    5 Market Performance for Manufacturers

    • 5.1 Europe Digital Biomarkers Sales (K Units) and Market Share by Manufacturers 2014-2020
    • 5.2 Europe Digital Biomarkers Revenue (M USD) and Market Share by Manufacturers 2014-2020
    • 5.3 Europe Digital Biomarkers Price (USD/Unit) of Manufacturers 2014-2020
    • 5.4 Europe Digital Biomarkers Gross Margin of Manufacturers 2014-2020
    • 5.5 Market Concentration

    6 Regions Market Performance for Manufacturers

    • 6.1 Germany Market Performance for Manufacturers
      • 6.1.1 Germany Digital Biomarkers Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.1.2 Germany Digital Biomarkers Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.1.3 Germany Digital Biomarkers Price (USD/Unit) of Manufacturers 2014-2020
      • 6.1.4 Germany Digital Biomarkers Gross Margin of Manufacturers 2014-2020
      • 6.1.5 Market Concentration
    • 6.2 UK Market Performance for Manufacturers
      • 6.2.1 UK Digital Biomarkers Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.2.2 UK Digital Biomarkers Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.2.3 UK Digital Biomarkers Price (USD/Unit) of Manufacturers 2014-2020
      • 6.2.4 UK Digital Biomarkers Gross Margin of Manufacturers 2014-2020
      • 6.2.5 Market Concentration
    • 6.3 France Market Performance for Manufacturers
      • 6.3.1 France Digital Biomarkers Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.3.2 France Digital Biomarkers Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.3.3 France Digital Biomarkers Price (USD/Unit) of Manufacturers 2014-2020
      • 6.3.4 France Digital Biomarkers Gross Margin of Manufacturers 2014-2020
      • 6.3.5 Market Concentration
    • 6.4 Russia Market Performance for Manufacturers
      • 6.4.1 Russia Digital Biomarkers Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.4.2 Russia Digital Biomarkers Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.4.3 Russia Digital Biomarkers Price (USD/Unit) of Manufacturers 2014-2020
      • 6.4.4 Russia Digital Biomarkers Gross Margin of Manufacturers 2014-2020
      • 6.4.5 Market Concentration
    • 6.5 Benelux Market Performance for Manufacturers
      • 6.5.1 Benelux Digital Biomarkers Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.5.2 Benelux Digital Biomarkers Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.5.3 Benelux Digital Biomarkers Price (USD/Unit) of Manufacturers 2014-2020
      • 6.5.4 Benelux Digital Biomarkers Gross Margin of Manufacturers 2014-2020
      • 6.5.5 Market Concentration
    • 6.6 Italy Market Performance for Manufacturers
      • 6.6.1 Italy Digital Biomarkers Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.6.2 Italy Digital Biomarkers Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.6.3 Italy Digital Biomarkers Price (USD/Unit) of Manufacturers 2014-2020
      • 6.6.4 Italy Digital Biomarkers Gross Margin of Manufacturers 2014-2020
      • 6.6.5 Market Concentration
    • 6.7 Spain Market Performance for Manufacturers
      • 6.7.1 Spain Digital Biomarkers Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.7.2 Spain Digital Biomarkers Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.7.3 Spain Digital Biomarkers Price (USD/Unit) of Manufacturers 2014-2020
      • 6.7.4 Spain Digital Biomarkers Gross Margin of Manufacturers 2014-2020
      • 6.7.5 Market Concentration
    • 6.8 Market Performance for Manufacturers
      • 6.8.1 Digital Biomarkers Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.8.2 Digital Biomarkers Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.8.3 Digital Biomarkers Price (USD/Unit) of Manufacturers 2014-2020
      • 6.8.4 Digital Biomarkers Gross Margin of Manufacturers 2014-2020
      • 6.8.5 Market Concentration

    7 Europe Digital Biomarkers Market Performance (Sales Point)

    • 7.1 Europe Digital Biomarkers Sales (K Units) and Market Share by Regions 2014-2020
    • 7.2 Europe Digital Biomarkers Revenue (M USD) and Market Share by Regions 2014-2020
    • 7.3 Europe Digital Biomarkers Price (USD/Unit) by Regions 2014-2020
    • 7.4 Europe Digital Biomarkers Gross Margin by Regions 2014-2020

    8 Development Trend for Regions (Sales Point)

    • 8.1 Europe Digital Biomarkers Sales and Growth, Sales Value and Growth Rate2014-2020
    • 8.2 Germany Digital Biomarkers Sales and Growth, Sales Value and Growth Rate2014-2020
    • 8.3 UK Digital Biomarkers Sales and Growth, Sales Value and Growth Rate2014-2020
    • 8.4 France Digital Biomarkers Sales and Growth, Sales Value and Growth Rate2014-2020
    • 8.5 Russia Digital Biomarkers Sales and Growth, Sales Value and Growth Rate2014-2020
    • 8.6 Benelux Digital Biomarkers Sales and Growth, Sales Value and Growth Rate2014-2020
    • 8.7 Italy Digital Biomarkers Sales and Growth, Sales Value and Growth Rate2014-2020
    • 8.8 Spain Digital Biomarkers Sales and Growth, Sales Value and Growth Rate2014-2020

    9 Upstream Source, Technology and Cost

    • 9.1 Upstream Source
    • 9.2 Technology
    • 9.3 Cost

    10 Channel Analysis

    • 10.1 Market Channel
    • 10.2 Distributors

    11 Consumer Analysis

    • 11.1 Sleep and Movement Industry
    • 11.2 Cardiovascular Industry
    • 11.3 Mood and Behavior Industry
    • 11.4 Pain Management Industry
    • 11.5 Neurodegenerative Disorders Industry
    • 11.6 Respiratory Conditions Industry

    12 Market Forecast 2021-2026

    • 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2021-2026
      • 12.1.1 Europe Digital Biomarkers Sales (K Units), Revenue (M USD) and Market Share by Regions 2021-2026
      • 12.1.2 Europe Digital Biomarkers Sales (K Units) and Growth Rate 2021-2026
      • 12.1.3 Germany Digital Biomarkers Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.4 UK Digital Biomarkers Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.5 France Digital Biomarkers Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.6 Russia Digital Biomarkers Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.7 Benelux Digital Biomarkers Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.8 Italy Digital Biomarkers Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.9 Spain Digital Biomarkers Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
    • 12.2 Sales (K Units) and Revenue (M USD) Forecast by Types 2021-2026
      • 12.2.1 Overall Market Performance
      • 12.2.2 Wellness Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.2.3 Disease Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.2.4 Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
    • 12.3 Sales Forecast by Application 2021-2026
      • 12.3.1 Overall Market Performance
      • 12.3.2 Sleep and Movement Sales and and Growth Rate 2021-2026
      • 12.3.3 Cardiovascular Sales and and Growth Rate 2021-2026
      • 12.3.4 Mood and Behavior Sales and and Growth Rate 2021-2026
      • 12.3.5 Pain Management Sales and and Growth Rate 2021-2026
      • 12.3.6 Neurodegenerative Disorders Sales and and Growth Rate 2021-2026
      • 12.3.7 Respiratory Conditions Sales and and Growth Rate 2021-2026
    • 12.4 Price (USD/Unit) and Gross Profit Forecast
      • 12.4.1 Europe Digital Biomarkers Price (USD/Unit) Trend 2021-2026
      • 12.4.2 Europe Digital Biomarkers Gross Profit Trend 2021-2026

    13 Conclusion

    In this report, the Digital Biomarkers market is expected to be valued at USD xxx billion by 2026, growing at a CAGR of xx% between 2020 and 2026. In this study, sales and sales value (million USD) of major players in Europe market will be included.
    Sales and revenue by type/application from 2014-2026.
    Industry chain, market trend, downstream and upstream information is also included.

    Geographically, this report split Europe into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Digital Biomarkers for these regions, from 2014 to 2026 (forecast), including
    Germany
    UK
    France
    Russia
    Benelux
    Italy
    Spain

    Europe Digital Biomarkers market competition by top manufacturers/players, with Digital Biomarkers sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    ActiGraph
    Akili Interactive Labs
    AliveCor
    Fitbit
    HumanAPI
    Novartis
    Pfizer
    F. Hoffmann-La Roche
    Sanofi
    Takeda Pharmaceuticals
    Verily Life Science

    On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
    Wellness
    Disease
    Drugs

    On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Digital Biomarkers for each application, including
    Sleep and Movement
    Cardiovascular
    Mood and Behavior
    Pain Management
    Neurodegenerative Disorders
    Respiratory Conditions

    If you have any special requirements, please let us know and we will offer you the report as you want.
    Buy now